These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35943712)

  • 1. Magistral Compounding with 3D Printing: A Promising Way to Achieve Personalized Medicine.
    Beer N; Kaae S; Genina N; Sporrong SK; Alves TL; Hoebert J; De Bruin ML; Hegger I
    Ther Innov Regul Sci; 2023 Jan; 57(1):26-36. PubMed ID: 35943712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scenarios for 3D printing of personalized medicines - A case study.
    Beer N; Hegger I; Kaae S; De Bruin ML; Genina N; Alves TL; Hoebert J; Kälvemark Sporrong S
    Explor Res Clin Soc Pharm; 2021 Dec; 4():100073. PubMed ID: 35479838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Digital Pharmacies Era: How 3D Printing Technology Using Fused Deposition Modeling Can Become a Reality.
    Araújo MRP; Sa-Barreto LL; Gratieri T; Gelfuso GM; Cunha-Filho M
    Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30893842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of three-dimensional printing for pediatric oral solid dosage forms.
    Kreft K; Fanous M; Möckel V
    Acta Pharm; 2024 Jun; 74(2):229-248. PubMed ID: 38815205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies.
    Buurma H; de Smet PA; van den Hoff OP; Sysling H; Storimans M; Egberts AC
    Pharm World Sci; 2003 Dec; 25(6):280-7. PubMed ID: 14689817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions, preferences and acceptability of patient designed 3D printed medicine by polypharmacy patients: a pilot study.
    Fastø MM; Genina N; Kaae S; Kälvemark Sporrong S
    Int J Clin Pharm; 2019 Oct; 41(5):1290-1298. PubMed ID: 31444687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [2D-3D printing in hospital pharmacies, what roles and challenges?].
    Annereau M; Toussaint B; Dufaÿ Wojcicki A; Dufaÿ S; Diaz Salmeron R; Boudy V
    Ann Pharm Fr; 2021 Jul; 79(4):361-374. PubMed ID: 33515591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.
    AlKhatib HS; Jalouqa S; Maraqa N; Ratka A; Elayeh E; Al Muhaissen S
    BMC Health Serv Res; 2019 Nov; 19(1):816. PubMed ID: 31703672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets.
    Sandler Topelius N; Shokraneh F; Bahman M; Lahtinen J; Hassinen N; Airaksinen S; Verma S; Hrizanovska L; Lass J; Paaver U; Tähnas J; Kern C; Lagarce F; Fenske D; Malik J; Scherliess H; Cruz SP; Paulsson M; Dekker J; Kammonen K; Rautamo M; Lück H; Pierrot A; Stareprawo S; Tubic-Grozdanis M; Zibolka S; Lösch U; Jeske M; Griesser U; Hummer K; Thalmeier A; Harjans A; Kruse A; Heimke-Brinck R; Khoukh K; Bruno F
    Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Outlook on the European and Italian Rules to Guarantee Magistral Formulas.
    Selmin F; Casiraghi A; Musazzi UM; Fortini M; Minghetti P
    Int J Pharm Compd; 2019; 23(1):6-12. PubMed ID: 30668530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing specialized compounding in community pharmacies.
    Giam JA; McLachlan AJ; Krass I
    Res Social Adm Pharm; 2012; 8(3):240-52. PubMed ID: 21824824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-Dimensional Printing of Medicinal Products and the Challenge of Personalized Therapy.
    Zema L; Melocchi A; Maroni A; Gazzaniga A
    J Pharm Sci; 2017 Jul; 106(7):1697-1705. PubMed ID: 28347731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D printing for personalised medicines: implications for policy and practice.
    Englezos K; Wang L; Tan ECK; Kang L
    Int J Pharm; 2023 Mar; 635():122785. PubMed ID: 36849040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practices of pharmacies that compound extemporaneous formulations.
    Treadway AK; Craddock D; Leff R
    Am J Health Syst Pharm; 2007 Jul; 64(13):1403-9. PubMed ID: 17592006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical Compounding in Portuguese Community Pharmacies: CHARACTERIZATION AND FUTURE PERSPECTIVES.
    Palmeira-de-Oliveira R; Macedo M; Machado RM; Pacheco AF; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Duarte P
    Int J Pharm Compd; 2016; 20(2):114-22. PubMed ID: 27323423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specialized compounding in community pharmacies: organizational perspective.
    Giam JA; McLachlan AJ; Krass I
    J Am Pharm Assoc (2003); 2010; 50(3):354-61. PubMed ID: 20452908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical Application of 3D Printing for Pharmaceuticals in Hospitals and Pharmacies.
    Huanbutta K; Burapapadh K; Sriamornsak P; Sangnim T
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D Printing Methods for Pharmaceutical Manufacturing: Opportunity and Challenges.
    Warsi MH; Yusuf M; Al Robaian M; Khan M; Muheem A; Khan S
    Curr Pharm Des; 2018; 24(42):4949-4956. PubMed ID: 30520367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Realities of Pharmaceutical Compounding in the Republic of Uzbekistan.
    Umarov U; Zdoryk O; Kolisnyk S; Fatkhullaeva M
    Int J Pharm Compd; 2021; 25(5):378-384. PubMed ID: 34623963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future.
    Allen LV
    Int J Pharm Compd; 2017; 21(4):293-298. PubMed ID: 28719372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.